Global Brucellosis Vaccines Competitive Landscape Professional Research Report 2025
Description
Global Brucellosis Vaccines Competitive Landscape Professional Research Report 2025
Research Summary
Brucellosis vaccines are immunizations designed to protect against brucellosis, a bacterial infection caused by species of the Brucella genus. Brucellosis affects various animals, including livestock such as cattle, goats, and pigs, as well as humans. The vaccines developed for brucellosis primarily target livestock populations, as they play a significant role in transmission to humans through consumption of contaminated animal products. Brucellosis vaccines are typically composed of live attenuated or inactivated Brucella strains, which stimulate the immune system to produce protective antibodies against the bacteria. These vaccines are administered to animals, either as a single-dose or multiple-dose regimen, to prevent or reduce the incidence of brucellosis in livestock populations. Vaccination programs are crucial in controlling and eradicating brucellosis, as they help reduce the spread of the disease, minimize economic losses in livestock production, and prevent zoonotic infections in humans. Effective brucellosis vaccines are an essential tool in managing this globally significant bacterial infection.
According to DIResearch's in-depth investigation and research, the global Brucellosis Vaccines market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Zoetis, Hester Biosciences, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Brucellosis Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Brucellosis Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Brucellosis Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Brucellosis Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Brucellosis Vaccines Include:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Zoetis
Hester Biosciences
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Brucellosis Vaccines Product Segment Include:
S19 Vaccine
RB51 Vaccine Strain
Brucellosis Vaccines Product Application Include:
Cattle
Sheep
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Brucellosis Vaccines Industry PESTEL Analysis
Chapter 3: Global Brucellosis Vaccines Industry Porter’s Five Forces Analysis
Chapter 4: Global Brucellosis Vaccines Major Regional Market Size and Forecast Analysis
Chapter 5: Global Brucellosis Vaccines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Brucellosis Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Brucellosis Vaccines Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Brucellosis Vaccines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Brucellosis Vaccines Product by Type
- 1.2.1 S19 Vaccine
- 1.2.2 RB51 Vaccine Strain
- 1.3 Brucellosis Vaccines Product by Application
- 1.3.1 Cattle
- 1.3.2 Sheep
- 1.3.3 Others
- 1.4 Global Brucellosis Vaccines Market Size Analysis (2020-2032)
- 1.5 Brucellosis Vaccines Market Development Status and Trends
- 1.5.1 Brucellosis Vaccines Industry Development Status Analysis
- 1.5.2 Brucellosis Vaccines Industry Development Trends Analysis
- 2 Brucellosis Vaccines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Brucellosis Vaccines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Brucellosis Vaccines Market Analysis by Regions
- 4.1 Brucellosis Vaccines Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Brucellosis Vaccines Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Brucellosis Vaccines Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Brucellosis Vaccines Revenue Forecast by Region (2026-2032)
- 5 Global Brucellosis Vaccines Market Size by Type and Application
- 5.1 Global Brucellosis Vaccines Market Size by Type (2020-2032)
- 5.2 Global Brucellosis Vaccines Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Brucellosis Vaccines Market Size by Type
- 6.4 North America Brucellosis Vaccines Market Size by Application
- 6.5 North America Brucellosis Vaccines Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Brucellosis Vaccines Market Size by Type
- 7.4 Europe Brucellosis Vaccines Market Size by Application
- 7.5 Europe Brucellosis Vaccines Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Brucellosis Vaccines Market Size by Type
- 8.4 China Brucellosis Vaccines Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Brucellosis Vaccines Market Size by Type
- 9.4 APAC (excl. China) Brucellosis Vaccines Market Size by Application
- 9.5 APAC (excl. China) Brucellosis Vaccines Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Brucellosis Vaccines Market Size by Type
- 10.4 Latin America Brucellosis Vaccines Market Size by Application
- 10.5 Latin America Brucellosis Vaccines Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Brucellosis Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Brucellosis Vaccines Market Size by Type
- 11.4 Middle East & Africa Brucellosis Vaccines Market Size by Application
- 11.5 Middle East & Africa Brucellosis Vaccines Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Brucellosis Vaccines Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Brucellosis Vaccines Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Brucellosis Vaccines Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Jinyu
- 13.1.1 Jinyu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Jinyu Brucellosis Vaccines Product Portfolio
- 13.1.3 Jinyu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Colorado Serum
- 13.2.1 Colorado Serum Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Colorado Serum Brucellosis Vaccines Product Portfolio
- 13.2.3 Colorado Serum Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Boehringer Ingelheim
- 13.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
- 13.3.3 Boehringer Ingelheim Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Biogenesis-Bago
- 13.4.1 Biogenesis-Bago Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
- 13.4.3 Biogenesis-Bago Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Vetal Company
- 13.5.1 Vetal Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Vetal Company Brucellosis Vaccines Product Portfolio
- 13.5.3 Vetal Company Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 CZ Veterinaria
- 13.6.1 CZ Veterinaria Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 CZ Veterinaria Brucellosis Vaccines Product Portfolio
- 13.6.3 CZ Veterinaria Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 SYVA Laboratorios
- 13.7.1 SYVA Laboratorios Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
- 13.7.3 SYVA Laboratorios Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Indian Immunologicals
- 13.8.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Indian Immunologicals Brucellosis Vaccines Product Portfolio
- 13.8.3 Indian Immunologicals Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Qilu
- 13.9.1 Qilu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Qilu Brucellosis Vaccines Product Portfolio
- 13.9.3 Qilu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Tecnovax
- 13.10.1 Tecnovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Tecnovax Brucellosis Vaccines Product Portfolio
- 13.10.3 Tecnovax Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Zoetis
- 13.11.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Zoetis Brucellosis Vaccines Product Portfolio
- 13.11.3 Zoetis Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Hester Biosciences
- 13.12.1 Hester Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Hester Biosciences Brucellosis Vaccines Product Portfolio
- 13.12.3 Hester Biosciences Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Onderstepoort Biological
- 13.13.1 Onderstepoort Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
- 13.13.3 Onderstepoort Biological Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Instituto Rosenbusch
- 13.14.1 Instituto Rosenbusch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
- 13.14.3 Instituto Rosenbusch Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Ceva Sante Animale
- 13.15.1 Ceva Sante Animale Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
- 13.15.3 Ceva Sante Animale Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Calier & Biologicos Laverlam
- 13.16.1 Calier & Biologicos Laverlam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
- 13.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Biovet
- 13.17.1 Biovet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Biovet Brucellosis Vaccines Product Portfolio
- 13.17.3 Biovet Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Brucellosis Vaccines Industry Chain Analysis
- 14.2 Brucellosis Vaccines Industry Raw Material and Suppliers Analysis
- 14.2.1 Brucellosis Vaccines Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Brucellosis Vaccines Typical Downstream Customers
- 14.4 Brucellosis Vaccines Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
